In late stages, liver cancer cells take advantages from the TGF-β-dependent pathways to acquire capabilities that contribute to tumor progression, such as production of autocrine mitogens, release of pro-metastatic cytokines and chemokines and up-regulation of receptors that mediate the response to them (10, 138–140). The gene discussed is TGFB1; the disease is liver cancer.